Filing Details

Accession Number:
0000950170-24-027442
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-06 18:45:39
Reporting Period:
2024-03-05
Accepted Time:
2024-03-06 18:45:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1858848 Tenaya Therapeutics Inc. TNYA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553333 Timothy Hoey C/O Tenaya Therapeutics, Inc.
171 Oyster Point Blvd., 5Th Floor
South San Francisco CA 94080
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-05 3,300 $7.00 245,346 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.
  2. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.01. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Includes 50,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.